Millennium Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $87.1M | Buy |
625,200
+232,400
| +59% | +$32.5M | 0.04% | 513 |
|
|
2025
Q4 | $48.2M | Sell |
392,800
-32,000
| -8% | -$3.89M | 0.02% | 842 |
|
|
2025
Q3 | $47.2M | Sell |
424,800
-370,100
| -47% | -$42.1M | 0.02% | 914 |
|
|
2025
Q2 | $88.1M | Sell |
794,900
-134,600
| -14% | -$14.3M | 0.04% | 460 |
|
|
2025
Q1 | $104M | Buy |
929,500
+478,500
| +106% | +$49.4M | 0.06% | 333 |
|
|
2024
Q4 | $41.7M | Sell |
451,000
-115,000
| -20% | -$10.4M | 0.02% | 907 |
|
|
2024
Q3 | $47.5M | Sell |
566,000
-59,100
| -9% | -$4.51M | 0.02% | 855 |
|
|
2024
Q2 | $42.9M | Sell |
625,100
-163,400
| -21% | -$10.9M | 0.02% | 904 |
|
|
2024
Q1 | $57.8M | Sell |
788,500
-268,800
| -25% | -$20.7M | 0.02% | 737 |
|
|
2023
Q4 | $85.7M | Sell |
1,057,300
-392,400
| -27% | -$30.5M | 0.04% | 488 |
|
|
2023
Q3 | $109M | Buy |
1,449,700
+474,500
| +49% | +$36.5M | 0.05% | 341 |
|
|
2023
Q2 | $75.2M | Sell |
975,200
-160,600
| -14% | -$12.8M | 0.04% | 496 |
|
|
2023
Q1 | $94.2M | Buy |
1,135,800
+167,200
| +17% | +$13.8M | 0.05% | 366 |
|
|
2022
Q4 | $83.2M | Sell |
968,600
-1,167,500
| -55% | -$92.5M | 0.05% | 469 |
|
|
2022
Q3 | $132M | Buy |
2,136,100
+787,000
| +58% | +$49.6M | 0.08% | 213 |
|
|
2022
Q2 | $83.4M | Buy |
1,349,100
+889,000
| +193% | +$55M | 0.05% | 377 |
|
|
2022
Q1 | $27.4M | Buy |
460,100
+130,000
| +39% | +$8.31M | 0.01% | 1090 |
|
|
2021
Q4 | $24M | Sell |
330,100
-91,100
| -22% | -$6.27M | 0.01% | 1284 |
|
|
2021
Q3 | $29.4M | Hold |
421,200
| – | – | 0.02% | 994 |
|
|
2021
Q2 | $29M | Sell |
421,200
-1,100
| -0.3% | -$73.5K | 0.02% | 918 |
|
|
2021
Q1 | $27.3M | Sell |
422,300
-133,800
| -24% | -$8.63M | 0.02% | 853 |
|
|
2020
Q4 | $32.4M | Buy |
556,100
+64,500
| +13% | +$3.89M | 0.02% | 730 |
|
|
2020
Q3 | $31.1K | Sell |
491,600
-8,000
| -2% | -$555K | 0.04% | 538 |
|
|
2020
Q2 | $38.4M | Sell |
499,600
-109,200
| -18% | -$8.37M | 0.05% | 404 |
|
|
2020
Q1 | $45.5M | Sell |
608,800
-174,500
| -22% | -$12.1M | 0.1% | 175 |
|
|
2019
Q4 | $50.9M | Buy |
783,300
+308,300
| +65% | +$20.1M | 0.06% | 358 |
|
|
2019
Q3 | $30.1M | Sell |
475,000
-259,300
| -35% | -$17M | 0.05% | 553 |
|
|
2019
Q2 | $49.6M | Sell |
734,300
-186,800
| -20% | -$12.3M | 0.07% | 348 |
|
|
2019
Q1 | $59.9M | Buy |
921,100
+901,100
| +4,506% | +$59.9M | 0.09% | 281 |
|
|
2018
Q4 | $1.25M | Buy |
+20,000
| New | +$1.4M | ﹤0.01% | 2474 |
|
|
2018
Q3 | – | Sell |
-130,000
| Closed | -$9.21M | – | 4038 |
|
|
2018
Q2 | $9.21M | Buy |
+130,000
| New | +$9.18M | 0.01% | 1376 |
|
|
2017
Q2 | – | Sell |
-200,000
| Closed | -$13.6M | – | 3601 |
|
|
2017
Q1 | $13.6M | Buy |
+200,000
| New | +$14.1M | 0.02% | 864 |
|
|
2016
Q4 | – | Sell |
-25,000
| Closed | -$1.98M | – | 3474 |
|
|
2016
Q3 | $1.98M | Buy |
+25,000
| New | +$2.03M | ﹤0.01% | 1938 |
|
|
2016
Q1 | – | Sell |
-180,000
| Closed | -$18.2M | – | 3409 |
|
|
2015
Q4 | $18.2M | Buy |
+180,000
| New | +$18.7M | 0.04% | 613 |
|
|
2015
Q1 | – | Sell |
-62,500
| Closed | -$5.89M | – | 3765 |
|
|
2014
Q4 | $5.89M | Buy |
62,500
+60,400
| +2,876% | +$6.25M | 0.01% | 1274 |
|
|
2014
Q3 | $224K | Sell |
2,100
-14,900
| -88% | -$1.46M | ﹤0.01% | 3338 |
|
|
2014
Q2 | $1.41M | Buy |
+17,000
| New | +$1.32M | ﹤0.01% | 1995 |
|
|
2014
Q1 | – | Sell |
-49,200
| Closed | -$3.69M | – | 3612 |
|
|
2013
Q4 | $3.69M | Buy |
+49,200
| New | +$3.43M | 0.01% | 1392 |
|
Other funds holding GILD
VCM
VPM
Millennium Management's GILD Position: Q1 2026 in Review
Millennium Management increased its Gilead Sciences (GILD) stake by 769% in Q1 2026, buying an estimated $146M and bringing the position to 1,180,760 shares worth $165M. The position accounts for 0.07% of the portfolio, ranked #261.
Millennium Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $284M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Millennium Management held 1,180,760 shares of Gilead Sciences worth $165M as of Q1 2026.
- Millennium Management bought 1,044,841 Gilead Sciences shares in Q1 2026, an estimated $146M.
- Gilead Sciences made up 0.07% of Millennium Management's portfolio in Q1 2026, its #261 holding.
- Millennium Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Gilead Sciences position peaked at $284M in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.